BRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial Results

Reuters11-13

BRIEF-Mersana <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Provides Business Update And Announces Q3 2024 Financial Results

Nov 13 (Reuters) - Mersana Therapeutics Inc MRSN.O:

MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS
MERSANA THERAPEUTICS: CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2024, WERE $155.2 MILLION

Source text: nGNXbJTT8g

Further company coverage: MRSN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483007600?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-13 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483007600","market":"us","top_or_hot":-1,"title":"BRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial Results","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Mersana <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Provides Business Update And Announces Q3 2024 Financial Results</title></head><body><p><span>Nov 13 (Reuters)</span><span> - </span>Mersana Therapeutics Inc <span>MRSN.O</span>:</p><ul><li><p>MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS</p></li><li><p>MERSANA THERAPEUTICS: CASH, CASH EQUIVALENTS &amp; MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2024, WERE $155.2 MILLION</p></li></ul><p>Source text: <span>nGNXbJTT8g</span></p><p>Further company coverage: <span>MRSN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-13 21:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA5X7XQW:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial ResultsNov 13 (Reuters) - Mersana Therapeutics Inc MRSN.O:MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA5X7XQW:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4563","symbol_name":"昨日强势股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA5X7XQW:1","article_id":"2483007600","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483007600","pubTimestamp":1731504511,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial ResultsNov 13  - Mersana Therapeutics Inc MRSN.O:MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTSMERSANA THERAPEUTICS: CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2024, WERE $155.2 MILLIONSource text: nGNXbJTT8gFurther company coverage: MRSN.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4563":"昨日强势股","MRSN":"Mersana Therapeutics Inc.","BK4139":"生物科技"},"translate_title":"简介-Mersana Therapeutics提供业务更新并公布2024年第三季度财务业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRSN":0.9},"content_text":"BRIEF-Mersana Therapeutics Provides Business Update And Announces Q3 2024 Financial ResultsNov 13 (Reuters) - Mersana Therapeutics Inc MRSN.O:MERSANA THERAPEUTICS PROVIDES BUSINESS UPDATE AND ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTSMERSANA THERAPEUTICS: CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES AS OF SEPTEMBER 30, 2024, WERE $155.2 MILLIONSource text: nGNXbJTT8gFurther company coverage: MRSN.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483007600"}